Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …

The immunoglobulin Y (IgY) derived from hyperimmune egg yolk is a promising passive
immune agent to combat microbial infections in humans and livestock. Numerous studies …

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the
19th century, their potential for use as biotechnological reagents has been exploited in …

Within the framework of the current COVID-19 pandemic, there is a race against time to find
therapies for the outbreak to be controlled. Since vaccines are still tedious to develop and …

Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are
considered one of the most effective weapons against COVID-19. During the first step of …

Background: Some viruses cause outbreaks, which require immediate attention.
Neutralizing antibodies could be developed for viral outbreak management. However, the …

Background/Objectives: The ongoing COVID-19 pandemic has underscored the need for
alternative prophylactic measures, particularly for populations for whom vaccines may not be …

There is no effective antibiotic against emerging highly resistant Acinetobacter baumannii
strains, and there is a need for alternative treatment options. Egg-yolk antibodies (IgYs) are …

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is the primary cause of the
Coronavirus disease 2019 (COVID-19) pandemic, which affects millions of people …

The high nutritional value and diverse functional properties of egg yolk proteins have led to
its widespread use in the fields of food, medicine, and cosmetics. Various extraction …